| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.47 | 0.4 |